The abstract is read at the publisher; the summary is JClub's.
Berbamine hydrochloride inhibits intracellular Gal3 puncta formation and crosses the blood-brain barrier, and in R6/2 Huntington’s disease mice it improves motor function while reducing mutant huntingtin aggregation.
- Why it matters: Galectin-3 drives microglial activation and neuroinflammation, but prior work lacked inhibitors that both modulate intracellular Gal3 and reach the brain.
- What they did: Using microglia expressing Gal3-GFP, the team screened ~24,000 small molecules with high-content imaging of Gal3 puncta after lysosomal damage, then tested berbamine hydrochloride’s effects in vitro and in R6/2 mice.
- The result: Berbamine hydrochloride disrupted Gal3 oligomerization and Gal3–TREM2 interaction, attenuated lipopolysaccharide-induced inflammation, restored dopaminergic and ciliary signaling pathways, and corrected Huntington’s disease-associated transcriptomic networks.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.